Helixgate

Helixgate

Helixgate

Helixgate

Premium Intelligence

Partnership Intelligence Briefings

Helixgate Partnership Intelligence Briefings are in‑depth editorial reports developed in collaboration with biotechnology innovators, research organizations, and technology leaders. These briefings explore emerging technologies, scientific breakthroughs, and the companies advancing the future of biotechnology and life‑science discovery.
AI & Machine Learning in Biotechnology2 weeks ago

STAT+: ‘We’re on the inside now’: Meet the man building a political empire behind RFK Jr.
AI & Machine Learning in Biotechnology2 weeks ago

STAT+: FDA approves Rocket gene therapy for rare immune disorder
AI & Machine Learning in Biotechnology2 weeks ago

STAT+: HHS convenes health care execs, motivational speaker on panel to modernize health care
AI & Machine Learning in Biotechnology2 weeks ago

Eli Lilly’s deal man, Allogene’s off-the-shelf CAR-T, and Merck’s Terns buy
AI & Machine Learning in Biotechnology2 weeks ago

STAT+: Denali Therapeutics, Corcept Therapeutics win FDA approvals
AI & Machine Learning in Biotechnology2 weeks ago

Health influencers talk social media and mental health
Synthetic Biology & Advanced Compound Production3 weeks ago

eXoZymes’ Cell-Free Biomanufacturing Platform Gets Positive Feedback from Cayman Chemical

eXoZymes’ Cell-Free Biomanufacturing Platform Gets Positive Feedback from Cayman Chemical
Synthetic Biology & Advanced Compound Production3 weeks ago

Electrorheoimaging Helps Manage Droplet Viscosity in Real-Time
Synthetic Biology & Advanced Compound Production3 weeks ago

HDX-MS Plus Computational Methods Provide Novel Approach to Study of Protein-Protein Interactions
Synthetic Biology & Advanced Compound Production3 weeks ago

Benchtop Bioreactor Simplifies Macrophage Manufacturing
Synthetic Biology & Advanced Compound Production3 weeks ago

CAR T Production Bottlenecks Best Tackled with AI, Automation, and Skilled Staff
More
Biotech Industry Intelligence2 weeks ago

Wave crashes on obesity disappointment

Wave crashes on obesity disappointment
Biotech Industry Intelligence2 weeks ago

Maze Loses Nearly a Third of Market Share on Mixed Midstage Kidney Drug Data
Biotech Industry Intelligence2 weeks ago

Boehringer Ingelheim plans for dealmaking and R&D spending amid US price pressure
Biotech Industry Intelligence2 weeks ago

Novo reports more triple-G data from China; Grifols plots IPO for biopharma unit
Biotech Industry Intelligence2 weeks ago

FDA posts photos of Indian drugmaking facility cited in warning letter
Biotech Industry Intelligence2 weeks ago

WuXi AppTec’s bet on the US pays off as revenues dip elsewhere
Biotech Industry Intelligence2 weeks ago

Former Acorda CEO Ron Cohen emerges at Parkinson’s cell therapy biotech Oryon
Biotech Industry Intelligence3 weeks ago

AstraZeneca deepens UK-China ties with cell therapy R&D hub, manufacturing plans
Biotech Industry Intelligence3 weeks ago

Collegium is acquiring Corium’s approved ADHD drug for $650M
More

Collaborate

Partnership Inquiries

Each briefing includes a technology overview, company background, innovation focus, executive perspective, and industry significance.

partners@helixgatebiotechreview.com